These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1231657)

  • 1. [Characteristics of various NAG vibriones isolated in Italy].
    Gatti M; Minelli G; Musiani M; Tarozzi L; Varoli O; Zerbini M
    Ann Sclavo; 1975 SEP-OCT; 17(5):740-8. PubMed ID: 1231657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of non-O1 Vibrio cholerae isolated from the effluents of a treatment plant.
    Gatti M; Stampi S; Donati M; De Luca G; Aschbacher R; Zanetti F
    New Microbiol; 1997 Oct; 20(4):311-8. PubMed ID: 9385600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyacrylamide gel electrophoresis and infrared spectroscopy of vibrio biotypes.
    Maiti M; Sur P; Chatterjee SN
    Can J Microbiol; 1981 Oct; 27(10):1048-52. PubMed ID: 7317857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vibrio cholera (Vibrio cholerae non-01) isolated in Poland from the Bug river].
    Stypułkowska-Misiurewicz H; Stasiak J; Janczyk M; Tomaszewska E; Pancer K
    Przegl Epidemiol; 1995; 49(3):237-43. PubMed ID: 7491417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Toxigenicity of NAG Vibrios.
    Draskovicová M; Karolcek J; Winkler
    Zentralbl Bakteriol Orig A; 1977 Feb; 237(1):65-71. PubMed ID: 842178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of populations heterogeneous according to O-antigen in Vibrio cholerae cultures.
    Andrusenko IT; Aleksandrova IK; Pidtilok EA; Ved'mina EA; Givental' NI; Pasternak NA; Shenderovich VA; Sobolev VR
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(2):177-84. PubMed ID: 6206130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical studies on lipopolysaccharide from agglutinable and non-agglutinable vibrios.
    Guhathakurta B; Dutta GC
    Appl Microbiol; 1974 Apr; 27(4):634-9. PubMed ID: 4207760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the phenol-induced flagellar agglutination test for the identification of the cholera group of vibrios.
    Pastoris MC; Bhattacharyya FK; Sil J
    J Med Microbiol; 1980 May; 13(2):362-7. PubMed ID: 7381922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses in rabbits to injections of whole cell, flagella, and flagellin preparations of cholera and noncholera vibrios.
    Smith HL
    Appl Microbiol; 1974 Feb; 27(2):375-8. PubMed ID: 4823423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on V. cholerae anti-antibodies (agglutinating and vibriocidal) in patients affected by cholera-like gastroenteritis. Studies performed during the cholera epidemic occurred in Apulia in August-September 1973].
    Barbuti S; Iandolo E; Rizzo G; Leogrande G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):449-59. PubMed ID: 1084731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-agglutinable vibrios (NAG-vibrios) and cholera (author's transl)].
    Muić V; Zekic R
    Lijec Vjesn; 1976 Jun; 98(6):307-8. PubMed ID: 979518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atypical forms of Vibrio cholerae].
    Andrusenko IT; Aleksandrova IK; Alekseenko VV; Ermolov VI
    Mikrobiol Zh (1978); 1983; 45(6):76-80. PubMed ID: 6086048
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Vibrio cholerae serotype 01 strains isolated from patients and the aquatic environment.
    Huq A; Parveen S; Qadri F; Sack DA; Colwell RR
    J Trop Med Hyg; 1993 Apr; 96(2):86-92. PubMed ID: 8459488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
    Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
    Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak due to Vibrio cholerae E1 Tor & serotype O139 in Yavatmal (Maharashtra) during June-July, 1994.
    Fule RP; Jalgaonkar SV; Ingole KV; Fule C
    Indian J Med Res; 1995 Feb; 101():62-3. PubMed ID: 7729850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inherent characteristics and DNA polymorphism of Vibrio cholerae and other vibrios.
    Wang J; Li Y; Shi J; Li L; Bai W; Yu A; Jiang S
    Chin Med J (Engl); 2002 Apr; 115(4):589-92. PubMed ID: 12133305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterization of Vibrio cholerae isolated in Kenya in 1983.
    Ichinose Y; Ehara M; Watanabe S; Shimodori S; Waiyaki PG; Kibue AM; Sang FC; Ngugi J; Kaviti JN
    J Trop Med Hyg; 1986 Oct; 89(5):269-76. PubMed ID: 3795327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial diversity during the cholera epidemic in Dakar, Senegal (1995-1996)].
    Sow AI; Cissé MF; Gaye M; Kébé A; Sy OK; Dia NM; Komo A
    Bull Soc Pathol Exot; 1997; 90(3):160-1. PubMed ID: 9410248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.